Ledger.Open graph →
SEC Form D · filed May 3, 2022

Ark Biotech Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Irving A. Fain · New York, NYDirectorYosef A. Quint · New York, NYExec · DirectorMcMorgan Infrastructure Fund II GP, LLC · San Francisco, CADirectorMichael Unglesbee · Minato-ku, Tokyo, M0DirectorYosef A. Quint · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗